Literature DB >> 19325542

Obesity, end-stage renal disease, and survival in an elderly cohort with cardiovascular disease.

Janice P Lea1, Daryl O Crenshaw, Stephen J Onufrak, Britt B Newsome, William M McClellan.   

Abstract

Obesity is highly prevalent in African Americans and is associated with increased risk of End-Stage Renal Disease (ESRD) and death. It is not known if the effect of obesity is similar among blacks and whites. The aim of this study is to examine racial differences in the association of obesity with ESRD and survival in elderly patients (age >65). Data were obtained for 74,167 Medicare patients with acute myocardial infarction (AMI) between February 1994 and July 1995. BMI was calculated as weight (kg) divided by height (m(2)). We evaluated the association of BMI class with ESRD incidence and death using multivariable Cox proportional hazards models, testing for race-BMI interactions. Compared to whites, African Americans had higher BMI (26.9 vs. 26.0, P < 0.0001) and estimated glomerular filtration rate (72.4 ml/min/1.73 m(2) vs. 66.6 ml/min/1.73 m(2), P < 0.0001). Crude ESRD rates increased with increasing obesity among whites but not among blacks. However, after adjusting for age, sex, and other comorbidities, obesity was not associated with increased ESRD rate among blacks or whites and the interaction between race and BMI was not significant. Furthermore, for both races, patients classified as overweight, class 1 obese, or class 2 obese had similar, significantly better survival abilities compared to normal weight patients and the race BMI interaction was not significant. In conclusion, obesity does not increase risk of ESRD among black or white elderly subjects with cardiovascular disease (CVD). However, both obese blacks and whites, in this population, experience a survival benefit. Further studies need to explore this obesity paradox.

Entities:  

Mesh:

Year:  2009        PMID: 19325542     DOI: 10.1038/oby.2009.70

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  6 in total

1.  Survival benefit of abdominal adiposity: a 6-year follow-up study with Dual X-ray absorptiometry in 3,978 older adults.

Authors:  Jenny Shun Wah Lee; Tung Wai Auyeung; Timothy Kwok; Martin Li; Jason Leung; Jean Woo
Journal:  Age (Dordr)       Date:  2011-06-11

Review 2.  The obesity paradox and cardiovascular disease.

Authors:  Stephen A Morse; Rajat Gulati; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

3.  Erythropoietin has a restorative effect on the contractility of arteries following experimental hypoxia.

Authors:  Sarah B Withers; Neha Passi; Alfred S Williams; Declan de Freitas; Anthony M Heagerty
Journal:  J Cardiovasc Dis Res       Date:  2013-10-16

4.  Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population.

Authors:  Quan-Lan Jasmine Lew; Tazeen Hasan Jafar; Mohammad Talaei; Aizhen Jin; Khuan Yew Chow; Jian-Min Yuan; Woon-Puay Koh
Journal:  Kidney Int       Date:  2017-05-18       Impact factor: 10.612

5.  Body mass index and survival after in-hospital cardiac arrest.

Authors:  Renuka Jain; Brahmajee K Nallamothu; Paul S Chan
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-08-10

6.  Long-term risk for end-stage kidney disease and death in a large population-based cohort.

Authors:  Emanuel Zitt; Constanze Pscheidt; Hans Concin; Reinhard Kramar; Raphael S Peter; Jan Beyersmann; Karl Lhotta; Gabriele Nagel
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.